AI

biotech

Data show cardiometabolic benefits of Type 2 diabetes treatment

Jim Cornall - June 10, 2026

biotech

Orphan Drug Designation for potential best-in-class ADC for sarcoma

Jim Cornall - June 9, 2026

biotech

FDA Breakthrough Therapy Designation for spinal muscular atrophy treatment

Jim Cornall - June 9, 2026

biotech

Servier acquiring Edgewise Therapeutics’ muscular dystrophy business

Jim Cornall - June 9, 2026

AI

Ryght AI and Biorasi to partner on AI

Jim Cornall - August 21, 2025

AI

Novel gene therapy for ALS cleared for trials in US and China

Jim Cornall - August 19, 2025

AI

Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins

Jim Cornall - August 19, 2025

AI

KAIST develops AI that automatically designs optimal drug candidates for cancer-targeting mutations

admin - August 11, 2025

AI

Base to Base biotech podcast 21: Elix drug discovery platform and CytoAgents on CAR-T, CRS and the FDA

Jim Cornall - August 8, 2025

AI

Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance

Jim Cornall - July 18, 2025

AI

Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity

Jim Cornall - July 4, 2025

AI

I-Corps Hub West accelerates deeptech commercialisation in western US

Jim Cornall - June 17, 2025

123...7 Page 2 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Data show cardiometabolic benefits of Type 2 diabetes treatment

Jim Cornall - June 10, 2026 0

Sparrow Pharmaceuticals, Inc. has announced positive phase 2 clinical data for clofutriben, its lead investigational 11β-hydroxysteroid dehydrogenase type 1 (HSD-1) inhibitor, in adults with...

Orphan Drug Designation for potential best-in-class ADC for sarcoma

biotech Jim Cornall - June 9, 2026 0

FDA Breakthrough Therapy Designation for spinal muscular atrophy treatment

biotech Jim Cornall - June 9, 2026 0

Servier acquiring Edgewise Therapeutics’ muscular dystrophy business

biotech Jim Cornall - June 9, 2026 0

Antibody fragment prevents haemorrhages associated with new Alzheimer’s treatments

biotech Jim Cornall - June 8, 2026 0